Latest News

Register now

ISAC is proud to support the upcoming 4th International Conference on Polymyxins.

Read More
Travel Grants to attend ...

Apply for Young Investigator &Eastern Europe Travel Grants for Istanbul.

Read More

Antibiotic susceptibility patterns used for epidemiologic surveillance of S. aureus

Organised by the ISAC MRSA Working Group

There have been recent studies in the US and Spain showing emerging resistance in MSSA to macrolides and to tetracyclines. ST398 S. aureus strains, initially identified as “livestock associated MRSA” are a fascinating example. Studies of clinical S. aureus strains have in some cases included molecular epidemiology suggesting that ST398 S. aureus strains may be responsible for a change in the relative prevalence of strains causing clinically significant disease. Other studies have examined national or transnational emergence of various increasingly common strains of MRSA and MSSA, using susceptibility patterns to track strain emergence or change over time. Join this webinar and hear from 3 experts in the field on these topics.


Optimising paediatric antibiotic therapy: a model-informed precision dosing approach

Optimising paediatric antibiotic therapy: a model-informed precision dosing approach

Organised by the ISAC Early Career Working Group

On-demand recording coming soon.

Join us for an insightful webinar titled "Optimising Paediatric Antibiotic Therapy: A Model-Informed Precision Dosing Approach." This session will delve into the cutting-edge methodologies of model-informed precision dosing (MIPD) to enhance antibiotic treatment in children. Discover how integrating pharmacometric models and clinical data can optimise dosing regimens, improve therapeutic outcomes, and minimise adverse effects. Ideal for healthcare professionals, researchers, and clinicians, this webinar will provide valuable knowledge and practical strategies to revolutionise paediatric antibiotic therapy. Don't miss this opportunity to learn from the leading expert in the field and advance your practice.

Fungal infections webinar

On-demand | Antifungal resistance in Candida and Aspergillus

Fungal infections, in their various manifestations, affect millions of people worldwide and cause a very high morbidity and mortality.

The new threats in the field of invasive mycoses and the new drugs recently available are reviewed in our recent webinar by internationally recognised experts.

Latest on-demand webinars

  • Antifungal resistance in Candida and Aspergillus
  • One health aspects of AMR and infections in Asia
  • Rapid diagnostics & strain typing in the era of increasing AMR
  • Ortho spinal infections in the era of increasing AMR
  • Phage pharmacology & therapy
  • H5N1 Avian Influenza: the path from panzootic to pandemic
  • Zero by 2023: One Health perspectives on rabies elimination
  • Beyond the pill: Transformative approaches to combat antimicrobial resistance
COVID-19: Webinar Series

COVID-19: Webinar Series

ISAC held six webinars in its COVID-19 series with the most recent being on COVID-19: re-vaccination & variant vaccines (September 2022).

Working Group Webinars

Working Group Webinars

ISAC's Working Groups have held several webinars on topics related to infectious diseases / antimicrobial resistance.

MDR Gram-negative bacilli

MDR Gram-negative bacilli

Held in collaboration with the Japanese Society for Chemotherapy.

ISAC / APUA Anniversary

ISAC / APUA Anniversary

ISAC and APUA celebrated 100 combined years of fighting ID and AMR in 2021.



The webinars provided by the International Society of Antimicrobial Chemotherapy (ISAC) are for informational purposes only. No material contained herein is intended to be a substitute for professional medical advice, diagnosis, treatment or national / local guidelines.
The opinions expressed in a webinar are those of the author(s) only and may not necessarily represent the views of ISAC. Where links are provided to other sites and resources of third parties, these links are provided for your information only. ISAC neither endorses not accepts responsibility for the contents of those sites or resources.